MDT - Medtronic: Now Is The Time To Buy This Deep Value Dividend Aristocrat

2024-06-14 07:30:00 ET

Summary

• When done right, pairing quality and value can be an especially potent investing strategy.
• Medtronic's revenue edged higher as currency-neutral non-GAAP EPS dipped a bit in the fiscal fourth quarter.
• Relative to its size, the company's $17 billion in net debt is quite manageable.
• MDT stock could be nearly 20% undervalued from the current share price.
• The MedTech company could be positioned for 45%+ cumulative total returns through fiscal year 2027.

Centering my portfolio around high-quality dividend stocks, I tend to be very much in tune with the get rich slowly mindset.

This is because, in my view, the speculation that leads to overnight wealth is unsustainable. The same wealth that was built overnight can be lost just as quickly....

For further details see: